These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9131434)

  • 1. E cadherin expression in normal and neoplastic canine mammary gland.
    Restucci B; Papparella S; De Vico G; Maiolino P
    J Comp Pathol; 1997 Feb; 116(2):191-202. PubMed ID: 9131434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-cadherin expression in canine mammary tissues.
    Gama A; Paredes J; Albergaria A; Gartner F; Schmitt F
    J Comp Pathol; 2004 Jan; 130(1):13-20. PubMed ID: 14693120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant P-cadherin expression is associated to aggressive feline mammary carcinomas.
    Figueira AC; Gomes C; de Oliveira JT; Vilhena H; Carvalheira J; de Matos AJ; Pereira PD; Gärtner F
    BMC Vet Res; 2014 Nov; 10():270. PubMed ID: 25424750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialyl Lewis x expression in canine malignant mammary tumours: correlation with clinicopathological features and E-Cadherin expression.
    Pinho SS; Matos AJ; Lopes C; Marcos NT; Carvalheira J; Reis CA; Gärtner F
    BMC Cancer; 2007 Jul; 7():124. PubMed ID: 17617904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
    Reis AL; Carvalheira J; Schmitt FC; Gärtner F
    Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E-cadherin immunoreactivity in canine mammary tumors.
    Sarli G; Preziosi R; De Tolla L; Brunetti B; Benazzi C
    J Vet Diagn Invest; 2004 Nov; 16(6):542-7. PubMed ID: 15586569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin expression in canine malignant mammary tumours: relationship to other clinico-pathological variables.
    Matos AJ; Lopes C; Carvalheira J; Santos M; Rutteman GR; Gärtner F
    J Comp Pathol; 2006; 134(2-3):182-9. PubMed ID: 16545841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands.
    Torres LN; Matera JM; Vasconcellos CH; Avanzo JL; Hernandez-Blazquez FJ; Dagli ML
    Vet Pathol; 2005 Sep; 42(5):633-41. PubMed ID: 16145209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The investigation of transcriptional repression mediated by ZEB2 in canine invasive micropapillary carcinoma in mammary gland.
    Gamba CO; Damasceno KA; Ferreira IC; Rodrigues MA; Gomes DA; Alves MR; Rocha RM; Lima AE; Ferreira E; Cassali GD
    PLoS One; 2019; 14(1):e0209497. PubMed ID: 30645591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cadherins and the mammary gland.
    Knudsen KA; Wheelock MJ
    J Cell Biochem; 2005 Jun; 95(3):488-96. PubMed ID: 15838893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin expression in canine mammary carcinomas with regional lymph node metastases.
    Brunetti B; Sarli G; Preziosi R; Leprotti S; Benazzi C
    J Vet Med A Physiol Pathol Clin Med; 2003 Dec; 50(10):496-500. PubMed ID: 15157016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-catenin, β-catenin and P-120-catenin immunoexpression in canine mammary tissues and their relationship with E-cadherin.
    da Rocha AA; Carvalheira J; Gärtner F
    Res Vet Sci; 2020 Jun; 130():197-202. PubMed ID: 32200159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of N-cadherin misexpression by the mammary epithelium in mice.
    Knudsen KA; Sauer C; Johnson KR; Wheelock MJ
    J Cell Biochem; 2005 Aug; 95(6):1093-107. PubMed ID: 15838877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical distribution of type IV collagenase in normal, dysplastic and neoplastic canine mammary gland.
    Papparella S; Restucci B; Maiolino P; De Vico G
    J Comp Pathol; 1997 Oct; 117(3):277-82. PubMed ID: 9447489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-cadherin expression in feline mammary tumors is associated with a reduced E-cadherin expression and the presence of regional metastasis.
    Buendia AJ; Peñafiel-Verdu C; Navarro JA; Vilafranca M; Sanchez J
    Vet Pathol; 2014 Jul; 51(4):755-8. PubMed ID: 24091815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decorin concentrations in canine normal and neoplastic mammary gland tissues.
    Szczubiał M; Kankofer M; Wawrzykowski J; Dąbrowski R; Łopuszyński W; Bochniarz M; Brodzki P
    Reprod Domest Anim; 2020 Oct; 55(10):1404-1410. PubMed ID: 33470009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
    Faustino AM; van Garderen E; Schalken JA; Nederbragt H
    J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.